State of the art of leadless pacing

Johannes Sperzel; Haran Burri; Daniel Gras; Fleur V. Y. Tjong; Reinoud E. Knops; Gerhard Hindricks; Clemens Steinwender; Pascal Defaye

doi:https://doi.org/10.1093/europace/euv096

State of the art of leadless pacing

Johannes Sperzel, Haran Burri, Daniel Gras, Fleur V. Y. Tjong, Reinoud E. Knops, Gerhard Hindricks, Clemens Steinwender, Pascal Defaye

Research output: Contribution to journal › Review article › Academic › peer-review

66 Citations (Scopus)

Abstract

Despite undisputable benefits, conventional pacemaker therapy is associated with specific complications related to the subcutaneous device and the transvenous leads. Recently, two miniaturized leadless pacemakers, Nanostim™ (St. Jude Medical) and Micra™ (Medtronic), which can be completely implanted inside the right ventricle using steerable delivery systems, entered clinical application. The WiCS™-cardiac resynchronisation therapy (CRT) system (wireless cardiac stimulation for CRT, EBR Systems) delivers leadless left ventricular endocardial stimulation for cardiac resynchronization. In addition to obvious cosmetic benefits, leadless pacing systems may have the potential to overcome some complications of conventional pacing. However, acute and long-term complications still remains to be determined, as well as the feasibility of device explantation years after device placement

Original language	English
Pages (from-to)	1508-1513
Journal	Europace : European pacing, arrhythmias, and cardiac electrophysiology
Volume	17
Issue number	10
DOIs	https://doi.org/10.1093/europace/euv096
Publication status	Published - 2015

Access to Document

https://doi.org/10.1093/europace/euv096

Cite this

@article{26b75ff867a64092a3163eec63dbf084,

title = "State of the art of leadless pacing",

abstract = "Despite undisputable benefits, conventional pacemaker therapy is associated with specific complications related to the subcutaneous device and the transvenous leads. Recently, two miniaturized leadless pacemakers, Nanostim{\texttrademark} (St. Jude Medical) and Micra{\texttrademark} (Medtronic), which can be completely implanted inside the right ventricle using steerable delivery systems, entered clinical application. The WiCS{\texttrademark}-cardiac resynchronisation therapy (CRT) system (wireless cardiac stimulation for CRT, EBR Systems) delivers leadless left ventricular endocardial stimulation for cardiac resynchronization. In addition to obvious cosmetic benefits, leadless pacing systems may have the potential to overcome some complications of conventional pacing. However, acute and long-term complications still remains to be determined, as well as the feasibility of device explantation years after device placement",

author = "Johannes Sperzel and Haran Burri and Daniel Gras and Tjong, {Fleur V. Y.} and Knops, {Reinoud E.} and Gerhard Hindricks and Clemens Steinwender and Pascal Defaye",

year = "2015",

doi = "https://doi.org/10.1093/europace/euv096",

language = "English",

volume = "17",

pages = "1508--1513",

journal = "Europace : European pacing, arrhythmias, and cardiac electrophysiology",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - State of the art of leadless pacing

AU - Sperzel, Johannes

AU - Burri, Haran

AU - Gras, Daniel

AU - Tjong, Fleur V. Y.

AU - Knops, Reinoud E.

AU - Hindricks, Gerhard

AU - Steinwender, Clemens

AU - Defaye, Pascal

PY - 2015

Y1 - 2015

N2 - Despite undisputable benefits, conventional pacemaker therapy is associated with specific complications related to the subcutaneous device and the transvenous leads. Recently, two miniaturized leadless pacemakers, Nanostim™ (St. Jude Medical) and Micra™ (Medtronic), which can be completely implanted inside the right ventricle using steerable delivery systems, entered clinical application. The WiCS™-cardiac resynchronisation therapy (CRT) system (wireless cardiac stimulation for CRT, EBR Systems) delivers leadless left ventricular endocardial stimulation for cardiac resynchronization. In addition to obvious cosmetic benefits, leadless pacing systems may have the potential to overcome some complications of conventional pacing. However, acute and long-term complications still remains to be determined, as well as the feasibility of device explantation years after device placement

AB - Despite undisputable benefits, conventional pacemaker therapy is associated with specific complications related to the subcutaneous device and the transvenous leads. Recently, two miniaturized leadless pacemakers, Nanostim™ (St. Jude Medical) and Micra™ (Medtronic), which can be completely implanted inside the right ventricle using steerable delivery systems, entered clinical application. The WiCS™-cardiac resynchronisation therapy (CRT) system (wireless cardiac stimulation for CRT, EBR Systems) delivers leadless left ventricular endocardial stimulation for cardiac resynchronization. In addition to obvious cosmetic benefits, leadless pacing systems may have the potential to overcome some complications of conventional pacing. However, acute and long-term complications still remains to be determined, as well as the feasibility of device explantation years after device placement

U2 - https://doi.org/10.1093/europace/euv096

DO - https://doi.org/10.1093/europace/euv096

M3 - Review article

C2 - 26024918

SN - 1099-5129

VL - 17

SP - 1508

EP - 1513

JO - Europace : European pacing, arrhythmias, and cardiac electrophysiology

JF - Europace : European pacing, arrhythmias, and cardiac electrophysiology

IS - 10

ER -